INTERNATIONAL PATENT: AGENDIA N.V., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA FILES APPLICATION FOR "PREDICTION OF RESPONSE TO IMMUNE THERAPY IN TRIPLE NEGATIVE BREAST CANCER PATIENTS."

GENEVA, Sept. 30 -- AGENDIA N.V. (Radarweg 601043 NT Amsterdam), THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (1111 Franklin Street12th FloorOakland, California 94607-5200) filed a patent application (PCT/NL2025/050134) for "PREDICTION OF RESPONSE TO IMMUNE THERAPY IN TRIPLE NEGATIVE BREAST CANCER PATIENTS." on Mar 18, 2025. With publication no. WO/2025/198469, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HAAN, Josien Carolien (c/o Radarweg 601043 NT Amsterdam), WEHKAMP, Diederik (c/o Radarweg 601043 NT Amsterdam), WOLF...